Antibody-drug conjugate combination therapy targeting LGR5 and MET with different payloads enhances efficacy in preclinical colorectal cancer models
- DOI
- 10.64898/2026.07.18.739355
- Published
- 2026-07-20
- Container
- Not recorded
- Publisher
- openRxiv
- Open access
- unknown
Credibility signals
uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.64898/2026.07.18.739355,
title = {Antibody-drug conjugate combination therapy targeting LGR5 and MET with different payloads enhances efficacy in preclinical colorectal cancer models},
author = {Shraddha Subramanian and Peyton C. High and Cara Guernsey-Biddle and Maya G. Cappellino and Sean P. Sullivan and Zhengdong Liang and Adela M. Aldana and Li Li and Sheng Pan and Kendra S. Carmon},
year = {2026},
doi = {10.64898/2026.07.18.739355},
url = {https://doi.org/10.64898/2026.07.18.739355}
}RIS
TY - JOUR TI - Antibody-drug conjugate combination therapy targeting LGR5 and MET with different payloads enhances efficacy in preclinical colorectal cancer models AU - Shraddha Subramanian AU - Peyton C. High AU - Cara Guernsey-Biddle AU - Maya G. Cappellino AU - Sean P. Sullivan AU - Zhengdong Liang AU - Adela M. Aldana AU - Li Li AU - Sheng Pan AU - Kendra S. Carmon PY - 2026 DO - 10.64898/2026.07.18.739355 UR - https://doi.org/10.64898/2026.07.18.739355 ER -
APA
Subramanian, S., High, P. C., Guernsey-Biddle, C., Cappellino, M. G., Sullivan, S. P., Liang, Z., Aldana, A. M., Li, L., Pan, S., & Carmon, K. S. (2026). Antibody-drug conjugate combination therapy targeting LGR5 and MET with different payloads enhances efficacy in preclinical colorectal cancer models. https://doi.org/10.64898/2026.07.18.739355
Source records
- crossref · retrieved 2026-11-09T20:36:17.952Z